Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck

Cancer Letters

Volumn 199, Issue 1, 2003, Pages 83-89

  Arany, Istvan ^a,b   Chen, San H ^a   Megyesi, Judit K ^b   Adler Storthz, Karen ^c   Chen, Z ^c   Rajaraman, Srinivasan ^a   Ember, Istvan A ^d   Tyring, Stephen K ^a   Brysk, Miriam M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF TEXAS DENTAL BRANCH AT HOUSTON   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Differentiation; Epidermal growth factor; Head; Neck; Signal transducer and activator of transcription; Tumors

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HEAD CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NECK CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TUMOR CELL;

EID: 0041878875     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00345-8     Document Type: Article

References (19)

1. Ke L.D., Adler-Storthz K., Clayman G.L., Yung A.W.K., Chen Z. Differential expression of epidermal growth factor receptor in human head and neck cancers. Head and Neck. 20:1997;320-327.
2. Arany I., Adler-Storthz K., Chen Z., Tyring S.K., Brysk H., Brysk M.M. Differentiation markers in oral carcinoma cell lines and tumors. Anticancer Research. 17:1997;4607-4610.
3. Arany I., Adler-Storthz K., Chen Z., Tyring S.K., Brysk M.M. Tumor differentiation-dependent local immunity in human head and neck cancers. Cancer Letters. 123:1998;173-176.
4. Grandis J.R., Drenning S.D., Chakroborty A., Zhou M.-Y., Zeng Q., Pitt A.S., Tweardy D.J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. Journal of Clinical Investigation. 102:1998;1385-1392.
5. Grandis J.R., Zeng Q., Drenning S.D. Epidermal growth factor receptor-mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope. 110:2000;868-874.
6. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., Kim J.D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proceedings of the National Academy of Sciences of the United States of America. 97:2000;4227-4232.
7. Song J.I., Grandis J.R. STAT signaling in head and neck cancer. Oncogene. 19:2000;2489-2495.
8. Brysk M.M., Arany I., Brysk H., Chen S.-H., Calhoun K.H., Tyring S.K. Gene expression of markers associated with proliferation and differentiation in keratinocytes cultured from skin and from oral mucosa. Archives of Oral Biology. 40:1995;855-862.
9. Brysk M.M., Bell T., Hoida C., Tyring S.K., Rajaraman S. Interferon-gamma modulates terminal differentiation and the expression of desquamin in cultured keratinocytes. Experimental Cell Research. 197:1991;140-147.
10. Brysk M.M., Arany I., Brysk H., Chen S.-H., Calhoun K.H., Tyring S.K. Epithelial cell responsiveness to interferon gamma: epidermis vs. buccal mucosa. Molecular and Cellular Differentiation. 3:1995;213-223.
11. Brysk M.M., Arany I., Brysk H., Chen S.H., Calhoun K.H., Tyring S.K. Gene expression of markers associated with proliferation and differentiation in human keratinocytes cultured from epidermis and from buccal mucosa. Archives of Oral Biology. 40:1995;855-862.
12. Arany I., Rady P., Tyring S.K. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway. Antiviral Research. 23:1994;131-141.
13. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Jr. Stat3 as an oncogene. Cell. 98:1999;295-303.
14. Nagpal J.K., Mishra R., Das B.R. Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis. Cancer. 94:2002;2393-2400.
15. Masuda M., Suzui M., Yasumatu R., Nakashima T., Kuratomi Y., Azuma K., Tomita K., Komiyama S., Weinstein I.B. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Research. 62:2002;3351-3355.
16. Kijima T., Niwa H., Steinman R.A., Drenning S.D., Gooding W.E., Wentzel A.L., Xi S., Grandis J.R. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth and Differentiation. 13:2002;355-362.
17. Barre B., Avril S., Coqueret O. Opposite regulation of Myc and p21waf1 transcription by STAT3 proteins. Journal of Biological Chemistry. 2002.
18. Carlos de Vicente J., Herrero-Zapatero A., Fresno M.F., Lopez-Arranz J.S. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncology. 38:2002;301-308.
19. Liberto M., Cobrinik D., Minden A. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene. 21:2002;1590-1599.